We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Approves Gilead's HIV Med; Rival Claims Infringement

Law360 (February 7, 2018, 10:39 PM EST) -- Hours after the U.S. Food and Drug Administration approved Gilead Sciences Inc.’s new HIV medication Biktarvy, rival ViiV Healthcare Co. filed a patent infringement lawsuit in Delaware federal court Wednesday accusing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.